|
POLI expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.987830E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.426770E-01 |
| Normal-vs-Stage2 |
6.926800E-01 |
| Normal-vs-Stage3 |
1.992300E-02 |
| Normal-vs-Stage4 |
1.673880E-02 |
| Stage1-vs-Stage2 |
6.811600E-01 |
| Stage1-vs-Stage3 |
9.046100E-04 |
| Stage1-vs-Stage4 |
4.246000E-02 |
| Stage2-vs-Stage3 |
4.357800E-02 |
| Stage2-vs-Stage4 |
7.663900E-02 |
| Stage3-vs-Stage4 |
7.394600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.584620E-01 |
| Normal-vs-AfricanAmerican |
8.542800E-01 |
| Normal-vs-Asian |
6.077800E-02 |
| Caucasian-vs-AfricanAmerican |
2.946800E-01 |
| Caucasian-vs-Asian |
1.886770E-01 |
| AfricanAmerican-vs-Asian |
1.988840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.409950E-01 |
| Normal-vs-Female |
7.097200E-01 |
| Male-vs-Female |
4.274400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.926400E-01 |
| Normal-vs-Extreme_Weight |
8.265600E-01 |
| Normal-vs-Obese |
3.841400E-01 |
| Normal-vs-Extreme_Obese |
2.544200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.950400E-01 |
| Normal_Weight-vs-Obese |
8.999000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.644200E-01 |
| Extreme_Weight-vs-Obese |
5.284600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.346000E-01 |
| Obese-vs-Extreme_Obese |
7.817800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.786200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.141600E-02 |
| Normal-vs-Age(61-80Yrs) |
6.929000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.058600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.522000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.762200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.510000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.962200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.006200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.887800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.627400E-04 |
| Normal-VS-Type2 PRCC |
6.223100E-04 |
| Normal-VS-KIRP CIMP |
2.81159999948599E-07 |
| Normal-VS-Unclassified PRCC |
3.238600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.77315972805081E-13 |
| Type1 PRCC-VS-KIRP CIMP |
2.37698749572246E-13 |
| Type1 PRCC-VS-Unclassified PRCC |
3.862000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.131840E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.835600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.959960E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.166000E-01 |
| Normal-vs-N1 |
3.976700E-03 |
| Normal-vs-N2 |
4.79680000164961E-08 |
| N0-vs-N1 |
6.840400E-02 |
| N0-vs-N2 |
6.58779999995751E-07 |
| N1-vs-N2 |
6.562300E-03 |
|
|
